Home › Attention Deficit Hyperactivity Disorder › Florida › Gainesville
Attention Deficit Hyperactivity Disorder clinical trials in Gainesville, FL
3 studies for Attention Deficit Hyperactivity Disorder are looking for participants at sites in and around Gainesville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
RecruitingPhase 3
- Clinical Research Site, Gainesville
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
RecruitingPhase 3
- Clinical Research Site, Gainesville
A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation
RecruitingPhase 3
- Sarkis Clinical Trials - Gainesville, Gainesville
About Attention Deficit Hyperactivity Disorder
Attention deficit hyperactive disorder (ADHD) is a neurodevelopmental disorder. Its main symptoms are inattention, hyperactivity, and impulsivity. Learn more.
More about Attention Deficit Hyperactivity Disorder on MedlinePlus
Attention Deficit Hyperactivity Disorder trials in other cities
- Boston, MA10 studies
- Cincinnati, OH8 studies
- Washington, DC7 studies
- Austin, TX7 studies
- Philadelphia, PA6 studies
- Las Vegas, NV6 studies
- Pittsburgh, PA5 studies
- Portland, OR5 studies
- Orlando, FL5 studies
- Atlanta, GA5 studies
- Jacksonville, FL5 studies
- Baltimore, MD4 studies
Other studies in Gainesville
- Heart Failure13 studies
- Type 1 Diabetes13 studies
- Parkinson's Disease12 studies
- Non-Small Cell Lung Cancer11 studies
- Breast Cancer11 studies
- Cancer (all types)9 studies
- Colorectal Cancer9 studies
- Cardiovascular Disease9 studies
- Lung Cancer9 studies
- Prostate Cancer8 studies
- Mild Cognitive Impairment8 studies
- Neuroblastoma7 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.